Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
However, they stand out for their motivations
Market potential Market for GLP-1 drugs to hit $100B by 2030 Goldman Sachs predicts the market for GLP-1 drugs will hit $100 billion by 2030
Foundayo: The Flexible Choice Foundayo, incorporating orforglipron, is a versatile pill offering without the constraints typical of many medications
Our platform is designed to be straightforward for first-time users
Among commercially insured non-diabetic individuals with obesity, people who identified as female, received point-of-service or preferred provider organization insurance coverage, and who took medications such as antidepressants or thyroid or hormone medications, were more likely to begin taking semaglutide compared to people who identified as males, or those who were covered by health management organization or exclusive provider organization plans
